Annual CFF
$4.47 M
-$320.52 M-98.63%
December 31, 2023
Summary
- As of February 23, 2025, NVAX annual cash flow from financing activities is $4.47 million, with the most recent change of -$320.52 million (-98.63%) on December 31, 2023.
- During the last 3 years, NVAX annual CFF has fallen by -$980.30 million (-99.55%).
- NVAX annual CFF is now -99.55% below its all-time high of $984.76 million, reached on December 31, 2020.
Performance
NVAX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$97.00 K
-$258.31 M-100.04%
September 30, 2024
Summary
- As of February 23, 2025, NVAX quarterly cash flow from financing activities is -$97.00 thousand, with the most recent change of -$258.31 million (-100.04%) on September 30, 2024.
- Over the past year, NVAX quarterly CFF has dropped by -$197.22 million (-100.05%).
- NVAX quarterly CFF is now -100.02% below its all-time high of $576.99 million, reached on March 31, 2021.
Performance
NVAX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$364.39 M
-$197.22 M-35.12%
September 30, 2024
Summary
- As of February 23, 2025, NVAX TTM cash flow from financing activities is $364.39 million, with the most recent change of -$197.22 million (-35.12%) on September 30, 2024.
- Over the past year, NVAX TTM CFF has increased by +$268.88 million (+281.50%).
- NVAX TTM CFF is now -73.51% below its all-time high of $1.38 billion, reached on March 31, 2021.
Performance
NVAX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
NVAX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -98.6% | -100.0% | +281.5% |
| 3 y3 years | -99.5% | +99.8% | -21.1% |
| 5 y5 years | -95.7% | -100.0% | +59.7% |
NVAX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.0% | at low | -100.0% | +100.0% | -35.1% | +292.5% |
| 5 y | 5-year | -99.5% | at low | -100.0% | +100.0% | -73.5% | +292.5% |
| alltime | all time | -99.5% | +720.3% | -100.0% | +100.0% | -73.5% | +292.5% |
Novavax Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$97.00 K(-100.0%) | $364.39 M(-35.1%) |
| Jun 2024 | - | $258.22 M(+4287.0%) | $561.61 M(+54.0%) |
| Mar 2024 | - | $5.89 M(-94.1%) | $364.73 M(+8066.8%) |
| Dec 2023 | $4.47 M(-98.6%) | $100.39 M(-49.1%) | $4.47 M(-95.3%) |
| Sep 2023 | - | $197.12 M(+221.4%) | $95.52 M(-172.0%) |
| Jun 2023 | - | $61.34 M(-117.3%) | -$132.58 M(-29.9%) |
| Mar 2023 | - | -$354.38 M(-285.1%) | -$189.26 M(-158.2%) |
| Dec 2022 | $324.99 M(-29.6%) | $191.44 M(-718.0%) | $324.99 M(+346.2%) |
| Sep 2022 | - | -$30.98 M(-764.9%) | $72.84 M(-17.3%) |
| Jun 2022 | - | $4.66 M(-97.1%) | $88.09 M(+97.6%) |
| Mar 2022 | - | $159.87 M(-363.3%) | $44.59 M(-90.3%) |
| Dec 2021 | $461.71 M(-53.1%) | -$60.71 M(+286.2%) | $461.71 M(-50.2%) |
| Sep 2021 | - | -$15.72 M(-59.5%) | $927.03 M(+0.7%) |
| Jun 2021 | - | -$38.84 M(-106.7%) | $920.37 M(-33.1%) |
| Mar 2021 | - | $576.99 M(+42.6%) | $1.38 B(+39.7%) |
| Dec 2020 | $984.76 M(+900.9%) | $404.61 M(-1907.3%) | $984.76 M(+61.4%) |
| Sep 2020 | - | -$22.39 M(-105.4%) | $610.32 M(-5.3%) |
| Jun 2020 | - | $416.62 M(+124.1%) | $644.74 M(+182.6%) |
| Mar 2020 | - | $185.92 M(+516.2%) | $228.13 M(+131.9%) |
| Dec 2019 | $98.38 M(-4.3%) | $30.17 M(+150.8%) | $98.38 M(+36.5%) |
| Sep 2019 | - | $12.03 M(>+9900.0%) | $72.07 M(+18.0%) |
| Jun 2019 | - | $3000.00(-100.0%) | $61.06 M(-46.9%) |
| Mar 2019 | - | $56.18 M(+1356.6%) | $115.06 M(+11.9%) |
| Dec 2018 | $102.81 M(+59.3%) | $3.86 M(+278.1%) | $102.81 M(-11.7%) |
| Sep 2018 | - | $1.02 M(-98.1%) | $116.36 M(-16.3%) |
| Jun 2018 | - | $54.00 M(+22.9%) | $138.97 M(+49.3%) |
| Mar 2018 | - | $43.92 M(+152.2%) | $93.10 M(+44.3%) |
| Dec 2017 | $64.54 M(-76.9%) | $17.41 M(-26.3%) | $64.54 M(+34.8%) |
| Sep 2017 | - | $23.63 M(+190.6%) | $47.89 M(+93.6%) |
| Jun 2017 | - | $8.13 M(-47.1%) | $24.74 M(+46.7%) |
| Mar 2017 | - | $15.36 M(+1908.4%) | $16.86 M(-94.0%) |
| Dec 2016 | $279.85 M(+34.4%) | $765.00 K(+59.4%) | $279.85 M(+0.2%) |
| Sep 2016 | - | $480.00 K(+89.7%) | $279.29 M(-2.8%) |
| Jun 2016 | - | $253.00 K(-99.9%) | $287.33 M(-1.3%) |
| Mar 2016 | - | $278.35 M(>+9900.0%) | $291.14 M(+39.8%) |
| Dec 2015 | $208.28 M(+89.8%) | $201.00 K(-97.6%) | $208.28 M(-0.0%) |
| Sep 2015 | - | $8.52 M(+109.7%) | $208.35 M(+4.0%) |
| Jun 2015 | - | $4.06 M(-97.9%) | $200.41 M(-34.1%) |
| Mar 2015 | - | $195.50 M(>+9900.0%) | $304.04 M(+177.1%) |
| Dec 2014 | $109.72 M(-16.3%) | $268.00 K(-53.9%) | $109.72 M(+0.2%) |
| Sep 2014 | - | $581.00 K(-99.5%) | $109.54 M(-52.0%) |
| Jun 2014 | - | $107.70 M(+9105.0%) | $228.33 M(+82.6%) |
| Mar 2014 | - | $1.17 M(+1171.7%) | $125.02 M(-4.6%) |
| Dec 2013 | $131.03 M(+143.6%) | $92.00 K(-99.9%) | $131.03 M(-17.1%) |
| Sep 2013 | - | $119.37 M(+2618.5%) | $157.97 M(+243.5%) |
| Jun 2013 | - | $4.39 M(-38.9%) | $45.98 M(-14.4%) |
| Mar 2013 | - | $7.18 M(-73.4%) | $53.71 M(-0.1%) |
| Dec 2012 | $53.79 M(+383.3%) | $27.03 M(+266.0%) | $53.79 M(+88.0%) |
| Sep 2012 | - | $7.38 M(-39.1%) | $28.61 M(+29.2%) |
| Jun 2012 | - | $12.12 M(+66.9%) | $22.15 M(+30.0%) |
| Mar 2012 | - | $7.26 M(+292.2%) | $17.04 M(+53.1%) |
| Dec 2011 | $11.13 M(-52.5%) | $1.85 M(+100.5%) | $11.13 M(+8.7%) |
| Sep 2011 | - | $923.00 K(-86.8%) | $10.24 M(-63.9%) |
| Jun 2011 | - | $7.00 M(+417.5%) | $28.36 M(+14.6%) |
| Mar 2011 | - | $1.35 M(+41.2%) | $24.74 M(+5.6%) |
| Dec 2010 | $23.43 M | $958.00 K(-95.0%) | $23.43 M(-46.1%) |
| Sep 2010 | - | $19.04 M(+461.9%) | $43.50 M(+30.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2010 | - | $3.39 M(+8818.4%) | $33.38 M(-22.3%) |
| Mar 2010 | - | $38.00 K(-99.8%) | $42.98 M(+1.6%) |
| Dec 2009 | $42.29 M(+148.9%) | $21.03 M(+135.7%) | $42.29 M(+97.3%) |
| Sep 2009 | - | $8.92 M(-31.3%) | $21.43 M(-28.6%) |
| Jun 2009 | - | $12.99 M(-2098.6%) | $30.02 M(+83.2%) |
| Mar 2009 | - | -$650.00 K(-480.1%) | $16.39 M(-3.6%) |
| Dec 2008 | $16.99 M(-2460.0%) | $171.00 K(-99.0%) | $16.99 M(+4.5%) |
| Sep 2008 | - | $17.51 M(-2806.6%) | $16.26 M(-1468.9%) |
| Jun 2008 | - | -$647.00 K(+1370.5%) | -$1.19 M(-12.2%) |
| Mar 2008 | - | -$44.00 K(-92.1%) | -$1.35 M(+87.9%) |
| Dec 2007 | -$720.00 K(-101.3%) | -$558.00 K(-1014.8%) | -$720.00 K(-248.1%) |
| Sep 2007 | - | $61.00 K(-107.5%) | $486.00 K(+224.0%) |
| Jun 2007 | - | -$812.00 K(-237.9%) | $150.00 K(-82.9%) |
| Mar 2007 | - | $589.00 K(-9.1%) | $879.00 K(-98.5%) |
| Dec 2006 | $56.89 M(+184.6%) | $648.00 K(-335.6%) | $56.89 M(-22.6%) |
| Sep 2006 | - | -$275.00 K(+231.3%) | $73.53 M(-4.7%) |
| Jun 2006 | - | -$83.00 K(-100.1%) | $77.12 M(+0.3%) |
| Mar 2006 | - | $56.60 M(+227.4%) | $76.90 M(+284.7%) |
| Dec 2005 | $19.99 M(-8.9%) | $17.29 M(+421.7%) | $19.99 M(+655.1%) |
| Sep 2005 | - | $3.31 M(-1172.5%) | $2.65 M(-87.8%) |
| Jun 2005 | - | -$309.00 K(+0.7%) | $21.70 M(-1.0%) |
| Mar 2005 | - | -$307.00 K(+502.0%) | $21.91 M(-0.2%) |
| Dec 2004 | $21.95 M(-50.2%) | -$51.00 K(-100.2%) | $21.95 M(-54.1%) |
| Sep 2004 | - | $22.36 M(<-9900.0%) | $47.81 M(+87.6%) |
| Jun 2004 | - | -$94.00 K(-65.2%) | $25.48 M(-5.8%) |
| Mar 2004 | - | -$270.00 K(-101.0%) | $27.04 M(-38.7%) |
| Dec 2003 | $44.09 M(+222.2%) | $25.81 M(>+9900.0%) | $44.09 M(+133.5%) |
| Sep 2003 | - | $41.00 K(-97.2%) | $18.88 M(+0.3%) |
| Jun 2003 | - | $1.47 M(-91.3%) | $18.83 M(-36.4%) |
| Mar 2003 | - | $16.78 M(+2724.9%) | $29.59 M(+116.2%) |
| Dec 2002 | $13.69 M(-11.2%) | $594.00 K(-7525.0%) | $13.69 M(-0.7%) |
| Sep 2002 | - | -$8000.00(-100.1%) | $13.78 M(-49.0%) |
| Jun 2002 | - | $12.22 M(+1292.1%) | $27.02 M(+73.1%) |
| Mar 2002 | - | $878.00 K(+27.4%) | $15.61 M(+1.3%) |
| Dec 2001 | $15.41 M(-59.0%) | $689.00 K(-94.8%) | $15.41 M(-56.7%) |
| Sep 2001 | - | $13.23 M(+1531.4%) | $35.58 M(+54.3%) |
| Jun 2001 | - | $811.00 K(+18.7%) | $23.05 M(+3.4%) |
| Mar 2001 | - | $683.00 K(-96.7%) | $22.30 M(-40.6%) |
| Dec 2000 | $37.56 M(+794.3%) | $20.85 M(+2836.6%) | $37.56 M(+123.4%) |
| Sep 2000 | - | $710.00 K(+1167.9%) | $16.81 M(+3.8%) |
| Jun 2000 | - | $56.00 K(-99.6%) | $16.20 M(-19.6%) |
| Mar 2000 | - | $15.94 M(>+9900.0%) | $20.14 M(+379.6%) |
| Dec 1999 | $4.20 M(+250.0%) | $100.00 K(0.0%) | $4.20 M(-481.8%) |
| Sep 1999 | - | $100.00 K(-97.5%) | -$1.10 M(0.0%) |
| Jun 1999 | - | $4.00 M(>+9900.0%) | -$1.10 M(-77.6%) |
| Mar 1999 | - | $0.00(-100.0%) | -$4.90 M(-508.3%) |
| Dec 1998 | $1.20 M(-77.8%) | -$5.20 M(-5300.0%) | $1.20 M(-82.1%) |
| Sep 1998 | - | $100.00 K(-50.0%) | $6.70 M(+1.5%) |
| Jun 1998 | - | $200.00 K(-96.7%) | $6.60 M(+1.5%) |
| Mar 1998 | - | $6.10 M(+1933.3%) | $6.50 M(+20.4%) |
| Dec 1997 | $5.40 M(+170.0%) | $300.00 K(>+9900.0%) | $5.40 M(-21.7%) |
| Sep 1997 | - | $0.00(-100.0%) | $6.90 M(0.0%) |
| Jun 1997 | - | $100.00 K(-98.0%) | $6.90 M(0.0%) |
| Mar 1997 | - | $5.00 M(+177.8%) | $6.90 M(+245.0%) |
| Dec 1996 | $2.00 M | $1.80 M(>+9900.0%) | $2.00 M(+900.0%) |
| Sep 1996 | - | $0.00(-100.0%) | $200.00 K(0.0%) |
| Jun 1996 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| Mar 1996 | - | $100.00 K | $100.00 K |
FAQ
- What is Novavax annual cash flow from financing activities?
- What is the all time high annual CFF for Novavax?
- What is Novavax annual CFF year-on-year change?
- What is Novavax quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Novavax?
- What is Novavax quarterly CFF year-on-year change?
- What is Novavax TTM cash flow from financing activities?
- What is the all time high TTM CFF for Novavax?
- What is Novavax TTM CFF year-on-year change?
What is Novavax annual cash flow from financing activities?
The current annual CFF of NVAX is $4.47 M
What is the all time high annual CFF for Novavax?
Novavax all-time high annual cash flow from financing activities is $984.76 M
What is Novavax annual CFF year-on-year change?
Over the past year, NVAX annual cash flow from financing activities has changed by -$320.52 M (-98.63%)
What is Novavax quarterly cash flow from financing activities?
The current quarterly CFF of NVAX is -$97.00 K
What is the all time high quarterly CFF for Novavax?
Novavax all-time high quarterly cash flow from financing activities is $576.99 M
What is Novavax quarterly CFF year-on-year change?
Over the past year, NVAX quarterly cash flow from financing activities has changed by -$197.22 M (-100.05%)
What is Novavax TTM cash flow from financing activities?
The current TTM CFF of NVAX is $364.39 M
What is the all time high TTM CFF for Novavax?
Novavax all-time high TTM cash flow from financing activities is $1.38 B
What is Novavax TTM CFF year-on-year change?
Over the past year, NVAX TTM cash flow from financing activities has changed by +$268.88 M (+281.50%)